Cardiovascular Devices Market to Reach $131.0 Billion by 2035

Cardiovascular devices market was valued at $72.0 billion in 2025 and is projected to reach $131.0 billion by 2035, growing at a CAGR of 6.20% during the forecast period (2026–2035). Market growth is driven by the increasing burden of cardiovascular diseases and rising adoption of advanced medical technologies. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for nearly 19.8 million casualties annually, or about 32% of total global casualties. This growing disease burden is significantly increasing demand for interventional cardiology devices, cardiac rhythm management systems, and structural heart solutions across healthcare systems globally. Additionally, expanding access to minimally invasive procedures and implantable cardiac technologies is improving patient outcomes and supporting market expansion.

Browse the full report description of “Cardiovascular Devices Market Size, Share & Trends Analysis Report by Technology (Minimally Invasive / Interventional Devices, Implantable Devices, Wearable Cardiac Monitoring Devices), by Product Type (Cardiac Rhythm Management Devices, Interventional Cardiology Devices, Structural Heart Devices, Cardiac Assist Devices, Surgical Devices), by End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Diagnostic Labs), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/cardiovascular-devices-market

Innovation Leaders Transforming the Cardiovascular Devices Market

The key players in the cardiovascular devices market include top companies such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, and Koninklijke Philips N.V., among others. The market is witnessing strong growth driven by increasing adoption of minimally invasive cardiovascular procedures and rapid technological advancements in implantable and monitoring devices. Hospitals and cardiac centers are expanding their capabilities to manage rising patient volumes and improve treatment outcomes. Additionally, innovations in wearable cardiac monitoring and transcatheter therapies are transforming disease management and patient care pathways.

• In March 2026, Medtronic plc announced results from its ALERT trial demonstrating that AI-enabled clinician alerts significantly improved the evaluation and treatment of patients with heart valve disease. The study showed a 40% increase in valve interventions and improved referral rates for minimally invasive procedures such as transcatheter aortic valve replacement (TAVR).

• In January 2026, Boston Scientific Corporation announced the first use of its PROMUS everolimus-eluting coronary stent system, marking an important milestone in interventional cardiology innovation. The device is designed to improve treatment outcomes in patients with coronary artery disease by delivering targeted drug therapy to prevent restenosis. Drug-eluting stents like PROMUS play a critical role in minimally invasive cardiovascular procedures, supporting the growing demand for advanced coronary intervention technologies.

• In August 2025, Abbott Laboratories announced that its Navitor transcatheter aortic valve implantation (TAVI) system received CE Mark approval in Europe for an expanded indication to treat patients with symptomatic severe aortic stenosis across low and intermediate surgical risk groups. This approval significantly broadens the eligible patient population and strengthens the adoption of minimally invasive structural heart therapies.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-
• By Product Type
• By Technology
• By End-User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, and Koninklijke Philips N.V., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cardiovascular Devices Market Report Segment

By Product Type

• Cardiac Rhythm Management Devices
• Interventional Cardiology Devices
• Structural Heart Devices
• Cardiac Assist Devices
• Surgical Devices

By Technology

• Minimally Invasive / Interventional Devices
• Implantable Devices
• Wearable Cardiac Monitoring Devices

By End-User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Diagnostic Labs

Global Cardiovascular Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cardiovascular-devices-market